Skip to content

A Decision Aid for Women With Early Stage Breast Cancer

Development and Evaluation of Different Versions of the Decision Board for Early Breast Cancer

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00201929
Enrollment
300
Registered
2005-09-20
Start date
2002-04-30
Completion date
2006-11-30
Last updated
2007-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

breast cancer, decision aid, Decision Board, information transfer

Brief summary

To enhance information transfer and decision making for women with breast cancer.

Detailed description

Our specific objectives are: (i) to develop computer and paper based versions of the Decision Boards for (a) chemotherapy for early stage breast cancer (chemotherapy versus no treatment), (b) mastectomy versus lumpectomy plus radiation and (ii) to compare the relative effectiveness of the computer and paper based versions with the standard Decision Board for patients with early breast cancer.

Interventions

PROCEDUREStandard Decision Board
PROCEDUREComputer Decision Board
PROCEDUREPaper Decision Board

Sponsors

U.S. Army Medical Research and Development Command
CollaboratorFED
Supportive Cancer Care Research Unit
CollaboratorUNKNOWN
Ontario Clinical Oncology Group (OCOG)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

Chemotherapy Group: * Female * Histologically documented invasive carcinoma of the breast treated with modified radical mastectomy or lumpectomy * Axillary node dissection * Chemotherapy alone or in addition to tamoxifen as an appropriate treatment option Surgery Group: * Female * Newly diagnosed carcinoma of the breast diagnosed either by cytology or pathological examination, OR if no biopsy, a strong clinical suspicion of malignancy * Clinical stage I or II disease * Candidate for breast conserving surgery

Exclusion criteria

Chemotherapy Group: * Candidate for CEF chemotherapy * Clinical evidence of metastatic disease * Serious comorbidity that would preclude receiving chemotherapy treatment * Unable to speak or read English fluently (including visual impairment) * Mentally incompetent including any psychiatric or addictive disorders that would preclude shared decision-making Surgery Group: * Previous surgery for breast cancer * Previous breast irradiation * Pregnant * Clinical suspicion of bilateral breast cancer * Serious comorbidity that would preclude definitive surgery * Unable to speak or read English fluently (including visual impairment) * Mentally incompetent including any psychiatric or addictive disorder that would preclude shared decision making

Design outcomes

Primary

MeasureTime frame
Patient comprehension
Patient satisfaction with information transfer

Secondary

MeasureTime frame
Patient satisfaction with decision making
Physician satisfaction with information transfer
Physician satisfaction with decision making
Time required for administration of the instrument
Patient preference for decision making

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026